NEO

#1955
NeoGenomics, Inc.
9.83
-0.71%
版块:
基础:
利润货币:
日范围
9.83
9.83
年范围
4.72
13.74
日变化
-0.71%
每月变动
-21.86%
6个月变化
+38.45%
年变化
+0.51%
前一天收盘价
9.90
Open
9.83
Bid
Ask
Low
9.83
High
9.83
交易量
119
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.26 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-14
Price to sales ratio
2.07
Dividends per share
—
Dividend yield %
—

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

新闻